January 2025
·
20 Reads
·
1 Citation
Nature
This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.
January 2025
·
20 Reads
·
1 Citation
Nature
December 2021
·
484 Reads
·
158 Citations
Science
Reversing the chain The mitochondrial electron transport chain is a major part of cellular metabolism and plays key roles in both cellular respiration and the synthesis of critical metabolites. Typically, electrons flow through the electron transport chain in a specific direction, ending up with oxygen as the terminal electron acceptor. Spinelli et al . characterized an alternative path of electron flow through the transport chain, ending with fumarate as the electron acceptor (see the Perspective by Baksh and Finley). This pathway operates under conditions of limited oxygen availability, and the authors have confirmed its activity in vivo in a mouse model, observing that the propensity to use this pathway varied between organs. —YN
January 2021
·
95 Reads
·
98 Citations
Proceedings of the National Academy of Sciences
Significance The mTORC1 eukaryotic cell growth regulator dynamically responds to changes in environmental nutrient levels. While many upstream regulators are known to modulate mTORC1 activity, the full complement of these is unknown. Here, using a genome-wide FACS-based CRISPR-Cas9 screen, we identify almost all known positive regulators of mTORC1 as well as many others. The results of our screens highlighted the importance of mitochondrial health in the regulation of mTORC1, which led us to investigate how mitochondrial stress impinges on mTORC1 signaling. Ultimately, we found that two kinases, AMPK and HRI, together signal mitochondrial distress to mTORC1. Furthermore, full inhibition of mTORC1 by mitochondrial stress requires the ATF4-dependent up-regulation of two mTORC1 pathway inhibitors, Sestrin2 and Redd1.
December 2020
·
137 Reads
·
79 Citations
Nature
Dozens of genes contribute to the wide variation in human pigmentation. Many of these genes encode proteins that localize to the melanosome—the organelle, related to the lysosome, that synthesizes pigment—but have unclear functions1,2. Here we describe MelanoIP, a method for rapidly isolating melanosomes and profiling their labile metabolite contents. We use this method to study MFSD12, a transmembrane protein of unknown molecular function that, when suppressed, causes darker pigmentation in mice and humans3,4. We find that MFSD12 is required to maintain normal levels of cystine—the oxidized dimer of cysteine—in melanosomes, and to produce cysteinyldopas, the precursors of pheomelanin synthesis made in melanosomes via cysteine oxidation5,6. Tracing and biochemical analyses show that MFSD12 is necessary for the import of cysteine into melanosomes and, in non-pigmented cells, lysosomes. Indeed, loss of MFSD12 reduced the accumulation of cystine in lysosomes of fibroblasts from patients with cystinosis, a lysosomal-storage disease caused by inactivation of the lysosomal cystine exporter cystinosin7–9. Thus, MFSD12 is an essential component of the cysteine importer for melanosomes and lysosomes.
October 2020
·
65 Reads
·
1 Citation
In mammalian cells, nutrients and growth factors signal through an array of upstream proteins to regulate the mTORC1 growth control pathway. Because the full complement of these proteins has not been systematically identified, we developed a FACS-based CRISPR-Cas9 genetic screening strategy to pinpoint genes that regulate mTORC1 activity. Along with almost all known positive components of the mTORC1 pathway, we identified many new genes that impact mTORC1 activity, including DCAF7, CSNK2B, SRSF2, IRS4, CCDC43 , and HSD17B10 . Using the genome-wide screening data, we generated a focused sublibrary containing single guide RNAs (sgRNAs) targeting hundreds of genes and carried out epistasis screens in cells lacking nutrient- and stress-responsive mTORC1 modulators, including GATOR1, AMPK, GCN2, and ATF4. From these data, we pinpointed mitochondrial function as a particularly important input into mTORC1 signaling. While it is well appreciated that mitochondria signal to mTORC1, the mechanisms are not completely clear. We find that the kinases AMPK and HRI signal, with varying kinetics, mitochondrial distress to mTORC1, and that HRI acts through the ATF4-dependent upregulation of both Sestrin2 and Redd1. Loss of both AMPK and HRI is sufficient to make mTORC1 largely resistant to mitochondrial dysfunction. Taken together, our data reveal a catalog of genes that impact the mTORC1 pathway and clarify the multifaceted ways in which mTORC1 senses mitochondrial dysfunction.
November 2019
·
129 Reads
·
281 Citations
Journal of Cell Science
The mechanistic target of rapamycin (mTOR) signaling pathway coordinates environmental and intracellular cues to control eukaryotic cell growth. As a pivot point between anabolic and catabolic processes, mTOR complex 1 (mTORC1) signaling has established roles in regulating metabolism, translation and autophagy. Hyperactivity of the mTOR pathway is associated with numerous human diseases, including diabetes, cancer and epilepsy. Pharmacological inhibition of the mTOR pathway can extend lifespan in a variety of model organisms. Given its broad control of essential cellular processes and clear relevance to human health, there is extensive interest in elucidating how upstream inputs regulate mTORC1 activation. In this Cell Science at a Glance article and accompanying poster, we summarize our understanding of how extracellular and intracellular signals feed into the mTOR pathway, how the lysosome acts as an mTOR signaling hub, and how downstream signaling controls autophagy and lysosome biogenesis.
April 2018
·
961 Reads
·
152 Citations
Nature
Nutrients, such as amino acids and glucose, signal through the Rag GTPases to activate mTORC1. The GATOR1 protein complex-comprising DEPDC5, NPRL2 and NPRL3-regulates the Rag GTPases as a GTPase-activating protein (GAP) for RAGA; loss of GATOR1 desensitizes mTORC1 signalling to nutrient starvation. GATOR1 components have no sequence homology to other proteins, so the function of GATOR1 at the molecular level is currently unknown. Here we used cryo-electron microscopy to solve structures of GATOR1 and GATOR1-Rag GTPases complexes. GATOR1 adopts an extended architecture with a cavity in the middle; NPRL2 links DEPDC5 and NPRL3, and DEPDC5 contacts the Rag GTPase heterodimer. Biochemical analyses reveal that our GATOR1-Rag GTPases structure is inhibitory, and that at least two binding modes must exist between the Rag GTPases and GATOR1. Direct interaction of DEPDC5 with RAGA inhibits GATOR1-mediated stimulation of GTP hydrolysis by RAGA, whereas weaker interactions between the NPRL2-NPRL3 heterodimer and RAGA execute GAP activity. These data reveal the structure of a component of the nutrient-sensing mTORC1 pathway and a non-canonical interaction between a GAP and its substrate GTPase.
November 2017
·
412 Reads
·
468 Citations
Science
SAMTOR joins the family The amino acid methionine is widely appreciated to have interesting effects on animal physiology. Diets low in methionine increase longevity and overall health, particularly glucose homeostasis. Gu et al. describe a potential molecular link between the effects of methionine restriction and the growth controller mTOR complex 1 (mTORC1), a well-validated regulator of life span and health span in many organisms. They identify a protein that they named SAMTOR as a component of the nutrient-sensing pathway upstream of mTORC1. SAMTOR directly binds S-adenosylmethionine (SAM), a metabolite made from methionine, and is necessary for regulating mTORC1 in response to methionine. Science , this issue p. 813
February 2017
·
272 Reads
·
258 Citations
Nature
The mechanistic target of rapamycin complex 1 (mTORC1) is a central regulator of cell growth that responds to diverse environmental signals and is deregulated in many human diseases, including cancer and epilepsy. Amino acids are a key input to this system, and act through the Rag GTPases to promote the translocation of mTORC1 to the lysosomal surface, its site of activation. Multiple protein complexes regulate the Rag GTPases in response to amino acids, including GATOR1, a GTPase activating protein for RAGA, and GATOR2, a positive regulator of unknown molecular function. Here we identify a protein complex (KICSTOR) that is composed of four proteins, KPTN, ITFG2, C12orf66 and SZT2, and that is required for amino acid or glucose deprivation to inhibit mTORC1 in cultured human cells. In mice that lack SZT2, mTORC1 signalling is increased in several tissues, including in neurons in the brain. KICSTOR localizes to lysosomes; binds and recruits GATOR1, but not GATOR2, to the lysosomal surface; and is necessary for the interaction of GATOR1 with its substrates, the Rag GTPases, and with GATOR2. Notably, several KICSTOR components are mutated in neurological diseases associated with mutations that lead to hyperactive mTORC1 signalling. Thus, KICSTOR is a lysosome-associated negative regulator of mTORC1 signalling, which, like GATOR1, is mutated in human disease.
December 2016
·
178 Reads
·
303 Citations
Nature Medicine
Mammalian tissues rely on a variety of nutrients to support their physiological functions. It is known that altered metabolism is involved in the pathogenesis of cancer, but which nutrients support the inappropriate growth of intact malignant tumors is incompletely understood. Amino acids are essential nutrients for many cancer cells that can be obtained through the scavenging and catabolism of extracellular protein via macropinocytosis. In particular, macropinocytosis can be a nutrient source for pancreatic cancer cells, but it is not fully understood how the tumor environment influences metabolic phenotypes and whether macropinocytosis supports the maintenance of amino acid levels within pancreatic tumors. Here we utilize miniaturized plasma exchange to deliver labeled albumin to tissues in live mice, and we demonstrate that breakdown of albumin contributes to the supply of free amino acids in pancreatic tumors. We also deliver albumin directly into tumors using an implantable microdevice, which was adapted and modified from ref. 9. Following implantation, we directly observe protein catabolism and macropinocytosis in situ by pancreatic cancer cells, but not by adjacent, non-cancerous pancreatic tissue. In addition, we find that intratumoral inhibition of macropinocytosis decreases amino acid levels. Taken together, these data suggest that pancreatic cancer cells consume extracellular protein, including albumin, and that this consumption serves as an important source of amino acids for pancreatic cancer cells in vivo.
... The findings were rather unexpected as lack of electron transfer to the respiratory chain results in excess of NADH, which inhibits the function of pyruvate dehydrogenase complex and the metabolic flow of the TCA cycle (28)(29)(30)(31). Apparently, the TCA cycle has a remarkable flexibility and reversibility in mammalian cells to sustain the metabolite supply in challenging situations when respiration is impaired (32)(33)(34). ...
December 2021
Science
... DDIT4 and SESN2 act downstream of ATF4 to inhibit Pol III activity and to modulate MAF1 phosphorylation The mTORC1 inhibitors DDIT4 and SESN2 are regulated by ATF4 [43][44][45][46][47]. Recent studies also suggest that DDIT4 and SESN2 contribute to mTORC1 inhibition following oligomycin treatment in HEK293T cells [ 48 ]. To determine if the ISR repressed Pol IIl activity through DDIT4 or SESN2, we generated a DDIT4 knockout line ( Supplementary Fig. S6 A), a SESN2 knockdown line ( Supplementary Fig. S6 B), and knocked down SESN2 in the DDIT4 knockout background. ...
January 2021
Proceedings of the National Academy of Sciences
... MFSD12 facilitates organellar cysteine transport and impacts melanin levels in melanocytes 13,22 . MPRA identified six GWAS MFVs (rs6510709, rs734454, rs10416746, rs7246261, rs142317543 and rs6510760) near MFSD12 that are not in linkage disequilibrium (LD) with each other (R 2 < 0.2; Extended Data Fig. 2 and Supplementary Fig. 11). ...
December 2020
Nature
... Notably, dysregulation of autophagy may contribute to the pathogenesis of neurodegenerative diseases 25 . mTORC1 serves as a central regulator of cell growth and metabolism in response to nutrient availability and growth factor signaling 12 . When nutrients and growth factors are abundant, mTORC1 is active, promoting cell growth and protein synthesis while inhibiting autophagy 26 . ...
November 2019
Journal of Cell Science
... org/) were used to predict the pathogenicity of the variants. Protein modeling was conducted to anticipate the impact of missense variants on molecular structure, which was achieved via SWISS-MODEL [16]. The PyMOL software subsequently facilitated three-dimensional protein structure visualization and analysis. ...
April 2018
Nature
... SAM is the first metabolite of the methionine cycle pathway and is critical for maintaining normal metabolic flux of the intracellular methionine cycle (Pascale et al. 2022). Notably, SAM becomes limited under specific nutritional conditions, with dietary MR significantly reducing tissue SAM levels (Gu et al. 2017). Moreover, methionine depletion will directly diminish the content of SAM in T cells (Bian et al. 2020). ...
November 2017
Science
... FKBP4, TULP3 and TSPAN9) were slightly downregulated with aging, except ITFG2, which was marginally upregulated in elderly HDFs. Interestingly, ITFG2 is a component of the KICSTOR complex which, under catabolic conditions, functions as a negative regulator in the amino acid-sensing branch of mTORC1, known to be activated in aging 66 . FKBP4 is among the top-5 genes most consistently downregulated with age across datasets for key mammalian tissues 67 , and TULP3 mutations cause multisystem fibrosis originating from disrupted ciliary composition and DNA damage 68 . ...
February 2017
Nature
... Pancreatic ductal adenocarcinoma (PDAC) subsists in a nutrient-deregulated microenvironment, making it particularly susceptible to treatments that interfere with cancer metabolism 1,2 . For example, PDAC uses, and is dependent on, high levels of autophagy and other lysosomal processes [3][4][5] . Although targeting these pathways has shown potential in preclinical studies, progress has been hampered by the difficulty in identifying and characterizing favourable targets for drug development 6 . ...
December 2016
Nature Medicine